Trilogy Capital Inc. Abbott Laboratories Transaction History
Trilogy Capital Inc.
- $1.92 Billion
- Q3 2024
A detailed history of Trilogy Capital Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Trilogy Capital Inc. holds 2,503 shares of ABT stock, worth $287,244. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,503
Previous 2,371
5.57%
Holding current value
$287,244
Previous $246,000
15.85%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.3 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.8 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.54 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.12 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $201B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...